Integrin Receptor Antagonist [EPC] - N0000175775

Pharmacologic Class Information

Pharmacologic Code N0000175775
Pharmacologic Name Integrin Receptor Antagonist
Pharmacologic Uses
  • integrin receptor antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Integrin Receptor Antagonist

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Integrin Receptor Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
64406-008Tysabri Non-Proprietary Name: NatalizumabInjectionIntravenousBiogen Inc.ACTIVE
64764-107Entyvio Non-Proprietary Name: VedolizumabInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
64764-108Entyvio Pen Non-Proprietary Name: VedolizumabInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
64764-300Entyvio Non-Proprietary Name: VedolizumabInjection, Powder, Lyophilized, For SolutionIntravenousTakeda Pharmaceuticals America, Inc.ACTIVE